Effect and safety of Neiguan acupoint injection with astragalus injection for chronic heart failure with qi-deficiency and blood-stasis syndrome: a randomized controlled trial
Dongmei Gou, Maomei He, Jiaquan Zhuo · 2026
Read Effect and safety of Neiguan acupoint injection with astragalus injection for chronic heart failure with qi-deficiency and blood-stasis syndrome: a randomized controlled trial by Dongmei Gou, Maomei He, Jiaquan Zhuo (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13253424.txt.
Description
Dongmei Gou, Maomei He, and Jiaquan Zhuo test an acupoint injection for chronic heart failure in a 2026 randomized, double-blind trial. The treatment injects astragalus extract, a traditional herbal preparation, into the Neiguan point on the forearm, which Chinese medicine links to heart function. The trial enrolled patients whose heart failure matched the qi-deficiency and blood-stasis pattern in that diagnostic system.
Two hundred patients received standard therapy plus either the real injection or a placebo, one hundred per group. After treatment, the injection group showed better symptom scores, lower levels of the heart strain marker BNP, and stronger pumping function. They also walked farther in six minutes and reported better quality of life. Readmissions did not differ, and no adverse events occurred in either arm. The authors conclude the add-on is safe and helpful for this patient pattern.
Catalog record
| CREATOR | Dongmei Gou, Maomei He, Jiaquan Zhuo |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 65 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |